Literature DB >> 21335972

Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population.

Yael D Reijmer1, Esther van den Berg, Sanne van Sonsbeek, Jaqueline M Dekker, Giel Nijpels, Coen D A Stehouwer, L Jaap Kappelle, Jaap L Kappelle, G J Biessels.   

Abstract

BACKGROUND/AIM: Cardiovascular risk factors play an important role in the development of cognitive impairment and dementia. We examined whether a previously designed dementia risk score based on midlife vascular risk profiles also predicts cognitive impairment 15 years later.
METHODS: 322 individuals without dementia from the population-based Hoorn study (aged 50-64 years) underwent a medical examination at baseline and a detailed cognitive assessment 15 years later. The relation between the risk score and late-life cognitive impairment in each of 6 domains was analyzed with logistic regression analysis.
RESULTS: The risk score was significantly related to impairment on the domains information-processing speed (p = 0.04), visuoconstruction (p = 0.04) and abstract reasoning (p = 0.02). Participants with a risk score of 9 points or more had a markedly increased risk of late-life impairment in the domains information-processing speed (OR 3.07, 95% CI 1.37-6.90; p = 0.007) and abstract reasoning (OR 3.97, 95% CI 1.07-14.71; p = 0.04).
CONCLUSION: A previously designed risk score for dementia also predicts late-life cognitive impairment. Because such impairment can lead to complaints and functional consequences, also in individuals who do not progress to dementia, identification of individuals at risk is important and can help to target preventive strategies.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335972     DOI: 10.1159/000324437

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  10 in total

1.  Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.

Authors:  Sara Kaffashian; Aline Dugravot; Alexis Elbaz; Martin J Shipley; Séverine Sabia; Mika Kivimäki; Archana Singh-Manoux
Journal:  Neurology       Date:  2013-04-02       Impact factor: 9.910

2.  Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort.

Authors:  Katherine J Bangen; Yian Gu; Alden L Gross; Brooke C Schneider; Jeannine C Skinner; Andreana Benitez; Bonnie C Sachs; Regina Shih; Shannon Sisco; Nicole Schupf; Richard Mayeux; Jennifer J Manly; José A Luchsinger
Journal:  J Am Geriatr Soc       Date:  2015-06-11       Impact factor: 5.562

3.  Dementia: Risk prediction models in dementia prevention.

Authors:  Alina Solomon; Hilkka Soininen
Journal:  Nat Rev Neurol       Date:  2015-05-19       Impact factor: 42.937

4.  APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.

Authors:  Katherine J Bangen; Alexa Beiser; Lisa Delano-Wood; Daniel A Nation; Melissa Lamar; David J Libon; Mark W Bondi; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-04-17       Impact factor: 2.136

5.  Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis.

Authors:  Ruth Stephen; Tiia Ngandu; Yawu Liu; Markku Peltonen; Riitta Antikainen; Nina Kemppainen; Tiina Laatikainen; Jyrki Lötjönen; Juha Rinne; Timo Strandberg; Jaakko Tuomilehto; Ritva Vanninen; Hilkka Soininen; Miia Kivipelto; Alina Solomon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-07-13       Impact factor: 6.053

Review 6.  Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review.

Authors:  Stephanie L Harrison; Jie Ding; Eugene Y H Tang; Mario Siervo; Louise Robinson; Carol Jagger; Blossom C M Stephan
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

7.  Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis.

Authors:  Ruth Peters; Andrew Booth; Kenneth Rockwood; Jean Peters; Catherine D'Este; Kaarin J Anstey
Journal:  BMJ Open       Date:  2019-01-25       Impact factor: 2.692

8.  Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.

Authors:  Ruth Stephen; Yawu Liu; Tiia Ngandu; Juha O Rinne; Nina Kemppainen; Riitta Parkkola; Tiina Laatikainen; Teemu Paajanen; Tuomo Hänninen; Timo Strandberg; Riitta Antikainen; Jaakko Tuomilehto; Sirkka Keinänen Kiukaanniemi; Ritva Vanninen; Seppo Helisalmi; Esko Levälahti; Miia Kivipelto; Hilkka Soininen; Alina Solomon
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Specific Effects of Anti-Hypertensive Treatment in an Older Patient with Dementia.

Authors:  Jadwiga Attier Zmudka; Jean Marie Sérot; Salif Dao; Claire Sorel; Anne-Sophie Macaret; Olivier Balédent
Journal:  Open Neurol J       Date:  2017-04-17

Review 10.  Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines.

Authors:  Kaarin J Anstey; Lidan Zheng; Ruth Peters; Scherazad Kootar; Mariagnese Barbera; Ruth Stephen; Tarun Dua; Neerja Chowdhary; Alina Solomon; Miia Kivipelto
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.